Effect of the GSK2245035 on the Allergen-induced Asthmatic Response (Q64140103)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of the GSK2245035 on the Allergen-induced Asthmatic Response |
clinical trial |
Statements
A Randomised, Double-blind, Placebo-controlled, Parallel Group, 8-week Treatment Study to Investigate the Safety, Pharmacodynamics, and Effect of the TLR7 Agonist, GSK2245035, on the Allergen-induced Asthmatic Response in Subjects With Mild Allergic Asthma (English)
0 references
5 December 2016
0 references
14 February 2018
0 references
36
0 references
18 year
0 references
65 year
0 references